Helen Of Troy
HELE
25.55
+0.23
+0.91%
Helen Of Troy
US · HELE
#3633 by market cap
25.55
+0.23
+0.91%
Live - 5344 symbols - heartbeat 267s ago
· 2026-10-08 09:20
Pre-market
30.77
+20.44%
After-hours
25.68
+0.49%
- Market cap
- 595.11M
- P/E (TTM)i
- -1.43
- P/Bi
- 0.71
- EPSi
- -39.08
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on HELE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.76, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -6.36% YoY
Margins
- Gross margin
- 45.66%
- Operating margin
- 5.98%
- Net margin
- -50.33%
Key ratios & quality
- Enterprise valuei
- 1.36B
- Altman Z-Scorei
- 1.76
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.56B | 1.71B | 2.10B | 2.22B | 2.07B | 2.01B | 1.91B | 1.79B |
| Gross profit | 641.11M | 734.47M | 927.30M | 953.19M | 899.35M | 948.66M | 914.41M | 815.69M |
| Selling & admin expenses | 438.14M | 511.90M | 637.01M | 680.26M | 660.20M | 669.36M | 705.38M | 708.91M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 202.97M | 222.56M | 290.29M | 272.93M | 239.15M | 279.30M | 209.03M | 106.79M |
| Pretax profit | 188.00M | 165.94M | 269.43M | 259.97M | 171.29M | 209.04M | 91.66M | -838.84M |
| Tax | 13.78M | 13.61M | 15.48M | 36.20M | 28.02M | 40.45M | -32.09M | 60.14M |
| Net profit | 168.55M | 152.33M | 253.95M | 223.76M | 143.27M | 168.59M | 123.75M | -898.98M |
| Basic EPS | 6 | 6 | 10 | 9 | 6 | 7 | 5 | -39 |
| Diluted EPS | 6.41 | 6.02 | 10.08 | 9.17 | 5.95 | 7.03 | 5.37 | -39.08 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 485.89M | 371.66M | 431.78M | 512.83M | 470.03M | 402.12M |
| Gross profit | 235.93M | 175.01M | 190.68M | 240.34M | 209.66M | 184.86M |
| Selling & admin expenses | 174.52M | 167.66M | 177.00M | 182.81M | 181.44M | 124.51M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 61.41M | 7.35M | 13.68M | 57.54M | 28.22M | 60.35M |
| Pretax profit | -11.61M | -420.54M | -329.69M | -24.01M | -64.60M | 48.32M |
| Tax | -62.53M | 30.18M | -21.05M | 60.04M | -9.03M | 12.56M |
| Net profit | 50.92M | -450.72M | -308.64M | -84.06M | -55.57M | 35.76M |
| Basic EPS | 2 | -20 | -13 | -4 | -2 | 2 |
| Diluted EPS | 2.22 | -19.65 | -13.44 | -3.65 | -2.41 | 1.51 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 604.86M | 682.84M | 971.94M | 1.08B | 892.04M | 843.92M | 931.71M | 865.52M |
| Cash & ST investments | 11.87M | 24.47M | 45.12M | 33.38M | 29.07M | 18.50M | 18.87M | 18.89M |
| Inventory | 302.34M | 256.31M | 481.61M | 557.99M | 455.49M | 396.00M | 452.62M | 455.81M |
| Total assets | 1.65B | 1.90B | 2.26B | 2.82B | 2.91B | 2.84B | 3.13B | 2.12B |
| Total current liabilities | 312.03M | 338.90M | 614.89M | 602.69M | 412.16M | 450.81M | 466.26M | 504.97M |
| Short-term debt | 1.88M | 1.88M | 1.88M | 1.88M | 6.06M | 6.25M | 9.38M | 25.00M |
| Long-term debt | 318.90M | 337.42M | 341.75M | 811.33M | 928.35M | 659.42M | 907.52M | 755.81M |
| Total liabilities | 652,898,000.00 | 742,160,000.00 | 1,024,141,000.00 | 1,496,112,000.00 | 1,424,904,000.00 | 1,201,180,000.00 | 1,448,644,000.00 | 1,317,351,000.00 |
| Total equity | 996.64M | 1.16B | 1.24B | 1.33B | 1.49B | 1.64B | 1.68B | 798.20M |
| Retained earnings | 746.37M | 898.17M | 965.17M | 1.02B | 1.16B | 1.28B | 1.31B | 412.79M |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 931.71M | 855.42M | 938.13M | 1.00B | 865.52M | 856.25M |
| Cash & ST investments | 18.87M | 22.67M | 22.37M | 27.14M | 18.89M | 21.68M |
| Inventory | 452.62M | 484.13M | 528.89M | 505.27M | 455.81M | 467.40M |
| Total assets | 3.13B | 2.65B | 2.41B | 2.34B | 2.12B | 2.08B |
| Total current liabilities | 466.26M | 504.51M | 549.95M | 554.06M | 504.97M | 480.19M |
| Short-term debt | 9.38M | 20.31M | 21.88M | 23.44M | 25.00M | 25.00M |
| Long-term debt | 907.52M | 850.70M | 871.35M | 868.96M | 755.81M | 691.15M |
| Total liabilities | 1,448,644,000.00 | 1,424,277,000.00 | 1,481,272,000.00 | 1,488,551,000.00 | 1,317,351,000.00 | 1,236,545,000.00 |
| Total equity | 1.68B | 1.23B | 926.28M | 852.26M | 798.20M | 843.52M |
| Retained earnings | 1.31B | 861.05M | 552.41M | 468.35M | 412.79M | 448.55M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 195.30M | 271.29M | 314.11M | 140.82M | 208.24M | 306.07M | 113.21M | 171.14M |
| Depreciation & amortization | 29.93M | 37.41M | 37.72M | 35.83M | 44.68M | 51.50M | 55.05M | 53.30M |
| Free cash flow | 168.92M | 253.53M | 215.44M | 62.78M | 33.38M | 269.42M | 83.14M | 131.91M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -217.49M | -10.17M | -203.29M | -188.20M | -18.37M | -55.22M | -103.19M | -1.92M |
| Ending cash balance | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | 34.98M | 58.34M | -10.47M | 11.95M | 111.32M | -636.00K |
| Depreciation & amortization | 14.20M | 14.08M | 12.86M | 12.84M | 13.51M | 13.38M |
| Free cash flow | 27.06M | 44.98M | -21.94M | 5.77M | 103.10M | -6.44M |
| Dividends paid | -- | -- | -- | 0 | -- | -- |
| Stock buybacks / issuance | -14.00K | -1.33M | -151.00K | -224.00K | -209.00K | -1.22M |
| Ending cash balance | -- | 22.67M | 22.37M | 27.14M | -- | 21.68M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.76 | 14.12 | 21.15 | 17.44 | 10.18 | 10.79 | 7.45 | -72.45 |
| ROA %i | 10.31 | 8.57 | 12.19 | 8.80 | 4.99 | 5.86 | 4.15 | -34.26 |
| ROIC %i | 13.66 | 11.36 | 16.81 | 12.34 | 7.63 | 8.80 | 6.62 | -40.46 |
| 5-year avg ROE %i | 12.03 | 12.14 | 14.16 | 14.77 | 15.93 | 14.73 | 13.40 | -5.32 |
| EBIT margin %i | 12.75 | 10.36 | 13.44 | 12.27 | 10.23 | 13.07 | 7.53 | -43.73 |
| FCF / sales %i | 10.80 | 14.85 | 10.26 | 2.82 | 1.61 | 13.44 | 4.36 | 7.38 |
| Current ratioi | 1.94 | 2.01 | 1.58 | 1.80 | 2.16 | 1.87 | 2.00 | 1.71 |
| Quick ratioi | 0.94 | 1.10 | 0.71 | 0.82 | 1.00 | 0.93 | 0.97 | 0.76 |
| Debt / assetsi | 19.45 | 19.97 | 16.88 | 30.35 | 33.53 | 24.76 | 30.55 | 39.41 |
| LT debt / equityi | 32.00 | 32.56 | 30.67 | 64.42 | 65.22 | 42.55 | 56.28 | 101.32 |
| Interest coveragei | 17.54 | 16.13 | 22.35 | 21.24 | 5.20 | 4.94 | 2.77 | -13.53 |
| Revenue CAGR (3Y) %i | 3.95 | 6.90 | 12.38 | 12.44 | 6.67 | -1.51 | -4.98 | -4.84 |
| Net income CAGR (3Y) %i | 18.52 | 2.69 | 78.77 | 9.91 | -2.02 | -12.76 | -17.92 | -- |
| FCF CAGR (3Y) %i | -0.19 | 5.98 | 0.76 | -28.10 | -49.13 | 7.74 | 9.81 | 58.10 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | 7.45 | -23.99 | -52.84 | -63.90 | -72.45 | -39.83 |
| ROA %i | 4.15 | -12.18 | -24.92 | -29.83 | -34.26 | -17.43 |
| ROIC %i | 6.62 | -12.61 | -29.10 | -35.54 | -40.46 | -20.18 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.53 | -15.79 | -35.41 | -40.39 | -43.73 | -17.27 |
| FCF / sales %i | 4.36 | 6.01 | 2.76 | 3.10 | 7.38 | 4.43 |
| Current ratioi | 2.00 | 1.70 | 1.71 | 1.81 | 1.71 | 1.78 |
| Quick ratioi | 0.97 | 0.69 | 0.69 | 0.85 | 0.76 | 0.74 |
| Debt / assetsi | 30.55 | 34.39 | 38.74 | 40.45 | 39.41 | 37.08 |
| LT debt / equityi | 56.28 | 72.63 | 98.33 | 108.35 | 101.32 | 88.48 |
| Interest coveragei | 2.77 | -5.53 | -11.89 | -12.58 | -13.53 | -5.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Beauty & Wellness is the largest reported line at 51.53% of revenue, across 2 reported segments.
- Home & Outdoor follows at 48.47%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Beauty & Wellness51.53%
Home & Outdoor48.47%
Quote time 2026-10-08 09:20:34 · For reference only, not investment advice and not tailored to your situation.